Pages that link to "Q34735017"

The following pages link to Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity (Q34735017):

Displaying 16 items.

• Stinging insect allergy: current perspectives on venom immunotherapy (Q26801123) (← links)
• Anaphylaxis to insect venom allergens: role of molecular diagnostics (Q28088677) (← links)
• Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement (Q30371972) (← links)
• Safety and efficacy of venom immunotherapy: a real life study (Q33645878) (← links)
• Venom immunotherapy: an updated review (Q38220704) (← links)
• Venom immunotherapy: clinical efficacy, safety and contraindications. (Q38505192) (← links)
• EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy. (Q38658310) (← links)
• Which immunotherapy product is better for patients allergic to Polistes venom? A laboratory and clinical study (Q38689341) (← links)
• Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines (Q38852323) (← links)
• Multi-organ dysfunction secondary to severe wasp envenomation (Q39224412) (← links)
• Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy (Q40217023) (← links)
• Predictors of clinical effectiveness of Hymenoptera venom immunotherapy. (Q44459579) (← links)
• Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement (Q51533907) (← links)
• [Sting challenge: indications and execution]. (Q52779212) (← links)
• IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper (Q90013236) (← links)
• Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings? (Q93186376) (← links)